IMRN
Immuron Limited American Depositary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
Immuron (IMRN) Stock: Buy, Sell, or Hold?
$0.91
-0.02 (-2.18%)
▼
5d:
+6.74%
30d:
-11.92%
90d:
-17.53%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (95%)
Quality Score
61/100
Position
SLIGHTLY LOW
30-Day Fair Range
$0.88 – $1.04
Position: SLIGHTLY LOW
Forward P/E & Valuation
-60.1x
Next 12M consensus est.
Wall Street Target
$2.58
+184.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.78 / $0.97
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: IMRN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Get Alerted When IMRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: IMRN is currently trading at $0.91, which is considered slightly low relative to its 30-day fair value range of $0.88 to $1.04.
Technical Outlook: Technically, IMRN is in a downtrend. Immediate support is located at $0.78, while resistance sits at $0.97.
Market Sentiment: IMRN scores 86/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.58 (+184.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMRN is in a downtrend. Immediate support is located at $0.78, while resistance sits at $0.97.
Market Sentiment: IMRN scores 86/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.58 (+184.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.88 -
$1.04
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$0.88 -
$1.04
Current vs Trading Range
SLIGHTLY LOW
Support Level
$0.78
Resistance Level
$0.97
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (86/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 184.8% below Wall St target ($2.58)
- BULLISH: Bottoming setup score 86/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-60.08
Wall Street Target
$2.58
(+184.8%)
Revenue Growth (YoY)
7.2%
Profit Margin
-47.7%
Share IMRN Analysis
Share this live IMRN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 12, 2026 7:53 PM ET
Data refreshes hourly during market hours. Next update: 8:53 PM
Data refreshes hourly during market hours. Next update: 8:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IMRN Research Pages
